In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration.

MLA

Kürti, Levente, et al. “In Vitro and in Vivo Characterization of Meloxicam Nanoparticles Designed for Nasal Administration.” European Journal of Pharmaceutical Sciences, vol. 50, no. 1, Sept. 2013, pp. 86–92. EBSCOhost, https://doi.org/10.1016/j.ejps.2013.03.012.

APA

Kürti, L., Gáspár, R., Márki, Á., Kápolna, E., Bocsik, A., Veszelka, S., Bartos, C., Ambrus, R., Vastag, M., Deli, M. A., & Szabó-Révész, P. (2013). In vitro and in vivo characterization of meloxicam nanoparticles designed for nasal administration. European Journal of Pharmaceutical Sciences, 50(1), 86–92. https://doi.org/10.1016/j.ejps.2013.03.012

Chicago

Kürti, Levente, Róbert Gáspár, Árpád Márki, Emese Kápolna, Alexandra Bocsik, Szilvia Veszelka, Csilla Bartos, et al. 2013. “In Vitro and in Vivo Characterization of Meloxicam Nanoparticles Designed for Nasal Administration.” European Journal of Pharmaceutical Sciences 50 (1): 86–92. doi:10.1016/j.ejps.2013.03.012.